Establishment and characterization of a human carcinoid in nude mice and effect of various agents on tumor growth (Q41670024)

From Wikidata

Jump to navigation Jump to search

scientific article published on August 1, 1991

Language	Label	Description	Also known as
English	Establishment and characterization of a human carcinoid in nude mice and effect of various agents on tumor growth	scientific article published on August 1, 1991

Statements

scholarly article

1 reference

Europe PubMed Central

6 October 2017

Establishment and characterization of a human carcinoid in nude mice and effect of various agents on tumor growth (English)

1 reference

10.1016/0016-5085(91)90004-5

https://api.crossref.org/works/10.1016/0016-5085(91)90004-5

5 November 2022

0 references

carcinoid tumor

1 reference

based on heuristic

inferred from title

cultured tumor cells

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1712329

5 November 2022

Courtney M. Townsend

2

object named as

Townsend CM Jr

1 reference

Europe PubMed Central

6 October 2017

1

object named as

Evers BM

1 reference

Europe PubMed Central

6 October 2017

author name string

J. R. Upp

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1712329

5 November 2022

E. Allen

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1712329

5 November 2022

S. C. Hurlbut

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1712329

5 November 2022

S. W. Kim

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1712329

5 November 2022

S. Rajaraman

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1712329

5 November 2022

P. Singh

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1712329

5 November 2022

J. C. Reubi

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1712329

5 November 2022

J. C. Thompson

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1712329

5 November 2022

language of work or name

0 references

publication date

1 August 1991

1 reference

Europe PubMed Central

6 October 2017

full work available at URL

https://api.elsevier.com/content/article/PII:0016508591900045?httpAccept=text/xml

1 reference

10.1016/0016-5085(91)90004-5

https://api.crossref.org/works/10.1016/0016-5085(91)90004-5

5 November 2022

https://api.elsevier.com/content/article/PII:0016508591900045?httpAccept=text/plain

1 reference

10.1016/0016-5085(91)90004-5

https://api.crossref.org/works/10.1016/0016-5085(91)90004-5

5 November 2022

Gastroenterology

1 reference

Europe PubMed Central

6 October 2017

101

1 reference

Europe PubMed Central

6 October 2017

303-311

1 reference

Europe PubMed Central

6 October 2017

2

1 reference

Europe PubMed Central

6 October 2017

describes a project that uses

0 references

Carcinoid apudomas

1

1 reference

10.1016/0016-5085(91)90004-5

https://api.crossref.org/works/10.1016/0016-5085(91)90004-5

5 November 2022

Carcinoids and carcinoid syndrome

2

1 reference

10.1016/0016-5085(91)90004-5

https://api.crossref.org/works/10.1016/0016-5085(91)90004-5

5 November 2022

Treatment of the carcinoid tumor and the malignant carcinoid syndrome

4

1 reference

10.1016/0016-5085(91)90004-5

https://api.crossref.org/works/10.1016/0016-5085(91)90004-5

5 November 2022

Regression of carcinoid tumour with cyproheptadine

5

1 reference

10.1016/0016-5085(91)90004-5

https://api.crossref.org/works/10.1016/0016-5085(91)90004-5

5 November 2022

Ketanserin versus placebo in carcinoid syndrome. A clinical controlled trial

6

1 reference

10.1016/0016-5085(91)90004-5

https://api.crossref.org/works/10.1016/0016-5085(91)90004-5

5 November 2022

Somatostatin, anaesthesia, and the carcinoid syndrome. Peri-operative administration of a somatostatin analogue to suppress carcinoid tumour activity.

13

1 reference

10.1016/0016-5085(91)90004-5

https://api.crossref.org/works/10.1016/0016-5085(91)90004-5

5 November 2022

Successful symptomatic treatment of malignant carcinoid syndrome with the somatostatin analogue SMS 201-995

14

1 reference

10.1016/0016-5085(91)90004-5

https://api.crossref.org/works/10.1016/0016-5085(91)90004-5

5 November 2022

Treatment of the malignant carcinoid syndrome. Evaluation of a long-acting somatostatin analogue

15

1 reference

10.1016/0016-5085(91)90004-5

https://api.crossref.org/works/10.1016/0016-5085(91)90004-5

5 November 2022

Use of somatostatin analog in management of carcinoid syndrome

16

1 reference

10.1016/0016-5085(91)90004-5

https://api.crossref.org/works/10.1016/0016-5085(91)90004-5

5 November 2022

Streptozocin plus fluorouracil versus doxorubicin therapy for metastatic carcinoid tumor

17

1 reference

10.1016/0016-5085(91)90004-5

https://api.crossref.org/works/10.1016/0016-5085(91)90004-5

5 November 2022

Combination chemotherapy trials in metastatic carcinoid tumor and the malignant carcinoid syndrome

18

1 reference

10.1016/0016-5085(91)90004-5

https://api.crossref.org/works/10.1016/0016-5085(91)90004-5

5 November 2022

Chemotherapy of metastatic carcinoid and islet cell tumors. A review

19

1 reference

10.1016/0016-5085(91)90004-5

https://api.crossref.org/works/10.1016/0016-5085(91)90004-5

5 November 2022

Inhibition of pentagastrin-stimulated up-regulation of gastrin receptors and growth of mouse colon tumor in vivo by proglumide, a gastrin receptor antagonist

22

1 reference

10.1016/0016-5085(91)90004-5

https://api.crossref.org/works/10.1016/0016-5085(91)90004-5

5 November 2022

Hormone-producing gastrointestinal tumors contain a high density of somatostatin receptors

23

1 reference

10.1016/0016-5085(91)90004-5

https://api.crossref.org/works/10.1016/0016-5085(91)90004-5

5 November 2022

Protein measurement with the Folin phenol reagent

25

1 reference

10.1016/0016-5085(91)90004-5

https://api.crossref.org/works/10.1016/0016-5085(91)90004-5

5 November 2022

A study of the conditions and mechanism of the diphenylamine reaction for the colorimetric estimation of deoxyribonucleic acid

26

1 reference

10.1016/0016-5085(91)90004-5

https://api.crossref.org/works/10.1016/0016-5085(91)90004-5

5 November 2022

Regulation of Pancreastatin Release from a Human Pancreatic Carcinoid Cell Line in Vitro*

29

1 reference

10.1016/0016-5085(91)90004-5

https://api.crossref.org/works/10.1016/0016-5085(91)90004-5

5 November 2022

Tachykinin production by carcinoid tumours in culture

31

1 reference

10.1016/0016-5085(91)90004-5

https://api.crossref.org/works/10.1016/0016-5085(91)90004-5

5 November 2022

Carcinoid tumour cells in long-term culture: release of serotonin but not of tachykinins on stimulation with adrenoceptor agonists

32

1 reference

10.1016/0016-5085(91)90004-5

https://api.crossref.org/works/10.1016/0016-5085(91)90004-5

5 November 2022

Serotonin and histamine production by human carcinoid cells in culture

33

1 reference

10.1016/0016-5085(91)90004-5

https://api.crossref.org/works/10.1016/0016-5085(91)90004-5

5 November 2022

Transplantable argyrophilic gastric carcinoid of Mastomys natalensis secreting both histamine and serotonin

34

1 reference

10.1016/0016-5085(91)90004-5

https://api.crossref.org/works/10.1016/0016-5085(91)90004-5

5 November 2022

Release of serotonin from human carcinoid tumor cells in vitro and grown in the anterior eye chamber of the rat

35

1 reference

10.1016/0016-5085(91)90004-5

https://api.crossref.org/works/10.1016/0016-5085(91)90004-5

5 November 2022

Successful transplantation of a human midgut carcinoid tumour to the anterior eye chamber of the rat

36

1 reference

10.1016/0016-5085(91)90004-5

https://api.crossref.org/works/10.1016/0016-5085(91)90004-5

5 November 2022

On the mode of action of the pentagastrin test in the carcinoid syndrome.

37

1 reference

10.1016/0016-5085(91)90004-5

https://api.crossref.org/works/10.1016/0016-5085(91)90004-5

5 November 2022

Somatostatin and Analogues in the Treatment of Cancer

39

1 reference

10.1016/0016-5085(91)90004-5

https://api.crossref.org/works/10.1016/0016-5085(91)90004-5

5 November 2022

Direct inhibitory effects of somatostatin (analogues) on the growth of human breast cancer cells

40

1 reference

10.1016/0016-5085(91)90004-5

https://api.crossref.org/works/10.1016/0016-5085(91)90004-5

5 November 2022

Antiproliferative effects of somatostatin and the somatostatin analog SMS 201-995 on three human breast cancer cell lines

42

1 reference

10.1016/0016-5085(91)90004-5

https://api.crossref.org/works/10.1016/0016-5085(91)90004-5

5 November 2022

Somatostatin analogs as adjuncts to agonists of luteinizing hormone-releasing hormone in the treatment of experimental prostate cancer

43

1 reference

10.1016/0016-5085(91)90004-5

https://api.crossref.org/works/10.1016/0016-5085(91)90004-5

5 November 2022

Inhibition of growth of two human pancreatic adenocarcinomas in vivo by somatostatin analog SMS 201-995.

44

1 reference

10.1016/0016-5085(91)90004-5

https://api.crossref.org/works/10.1016/0016-5085(91)90004-5

5 November 2022

A somatostatin analogue inhibits chondrosarcoma and insulinoma tumour growth.

46

1 reference

10.1016/0016-5085(91)90004-5

https://api.crossref.org/works/10.1016/0016-5085(91)90004-5

5 November 2022

Clinical and hormonal effects of a long-acting somatostatin analogue in pancreatic endocrine tumors and in carcinoid syndrome

48

1 reference

10.1016/0016-5085(91)90004-5

https://api.crossref.org/works/10.1016/0016-5085(91)90004-5

5 November 2022

Use of a somatostatin analogue in association with surgery and hepatic arterial embolisation in the treatment of the carcinoid syndrome

49

1 reference

10.1016/0016-5085(91)90004-5

https://api.crossref.org/works/10.1016/0016-5085(91)90004-5

5 November 2022

Chemotherapeutic implications of polyamine biosynthesis inhibition

50

1 reference

10.1016/0016-5085(91)90004-5

https://api.crossref.org/works/10.1016/0016-5085(91)90004-5

5 November 2022

Heterogeneous survival responses of human gastric cancer clones to alpha difluoromethylornithine in vitro

55

1 reference

10.1016/0016-5085(91)90004-5

https://api.crossref.org/works/10.1016/0016-5085(91)90004-5

5 November 2022

Identifiers

10.1016/0016-5085(91)90004-5

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1712329

5 November 2022

1 reference

Europe PubMed Central

6 October 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41670024&oldid=1765360502"